Ferdous Hakim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ferdous Hakim has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Mostafa Zaman
Department of Public Health and Informatics, Bangladesh Medical University, Dhaka, Bangladesh
5 shared publications - Rijwan Bhuiyan
Bangladesh Medical University
5 shared publications - Pablo Perel
World Heart Federation, Geneva, Switzerland
3 shared publications - Ambuj Roy
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, Delhi, India
2 shared publications - Amitava Banerjee
Institute of Health Informatics, University College London, London, UK
2 shared publications - Carolyn Su Ping Lam
National Heart Centre Singapore and Duke-National University of Singapore, Singapore
2 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by European Publishing in Population Medicine
- Vol. 8 (2) , 1-11
Prevalence and determinants of intention to quit smoking tobacco among adult males in Bangladesh: Findings from a cross-sectional national survey
Introduction: Smoking is one of the leading preventable risk factors associated with non-communicable disease-related deaths globally and in Bangladesh. Having a goal to quit smoking is a key step towards stopping smoking. However, data are scarce, and a unified national tobacco cessation...
- 29 June 2026
- Published by European Publishing in Population Medicine
- Vol. 8 (2) , 1-11
Open AccessPrevalence and determinants of intention to quit smoking tobacco among adult males in Bangladesh: Findings from a cross-sectional national survey
Introduction: Smoking is one of the leading preventable risk factors associated with non-communicable disease-related deaths globally and in Bangladesh. Having a goal to quit smoking is a key step towards stopping smoking. However, data are scarce, and a unified national tobacco cessation...
- Open Access
Seroprevalence of SARS-CoV-2 antibodies among Forcibly Displaced Myanmar Nationals in Cox’s Bazar, Bangladesh 2020: a population-based cross-sectional study
Objectives The study aimed to determine the seroprevalence, the fraction of asymptomatic infections, and risk factors of SARS-CoV-2 infections among the Forcibly Displaced Myanmar Nationals (FDMNs). Design It was a population-based two-stage cross-sectional study at the level of households. Setting The study was conducted in December 2020 among household members of the FDMN population living in the 34 camps of Ukhia and Teknaf Upazila of Cox’s Bazar district in Bangladesh. Participants Among 860 697 FDMNs residing in 187 517 households, 3446 were recruited for the study. One individual aged 1 year or older was randomly selected from each targeted household. Primary and secondary outcome measures Blood samples from respondents were tested for total antibodies for SARS-CoV-2 using Wantai ELISA kits, and later positive samples were validated by Kantaro kits. Results More than half (55.3%) of the respondents were females, aged 23 median (IQR 14–35) years and more than half (58.4%) had no formal education. Overall, 2090 of 3446 study participants tested positive for SARS-CoV-2 antibody. The weighted and test adjusted seroprevalence (95% CI) was 48.3% (45.3% to 51.4%), which did not differ by the sexes. Children (aged 1–17 years) had a significantly lower seroprevalence 38.6% (95% CI 33.8% to 43.4%) compared with adults (58.1%, 95% CI 55.2% to 61.1%). Almost half (45.7%, 95% CI 41.9% to 49.5%) of seropositive individuals reported no relevant symptoms since March 2020. Antibody seroprevalence was higher in those with any comorbidity (57.8%, 95% CI 50.4% to 64.5%) than those without (47.2%, 95% CI 43.9% to 50.4%). Multivariate logistic regression analysis of all subjects identified increasing age and education as risk factors for seropositivity. In children (≤17 years), only age was significantly associated with the infection. Conclusions In December 2020, about half of the FDMNs had antibodies against SARS-CoV-2, including those who reported no history of symptoms. Periodic serosurveys are necessary to recommend appropriate public health measures to limit transmission.
Open AccessSeroprevalence of SARS-CoV-2 antibodies among Forcibly Displaced Myanmar Nationals in Cox’s Bazar, Bangladesh 2020: a population-based cross-sectional study
Objectives The study aimed to determine the seroprevalence, the fraction of asymptomatic infections, and risk factors of SARS-CoV-2 infections among the Forcibly Displaced Myanmar Nationals (FDMNs). Design It was a population-based two-stage cross-sectional study at the level of households. Setting The study was conducted in December 2020 among household members of the FDMN population living in the 34 camps of Ukhia and Teknaf Upazila of Cox’s Bazar district in Bangladesh. Participants Among 860 697 FDMNs residing in 187 517 households, 3446 were recruited for the study. One individual aged 1 year or older was randomly selected from each targeted household. Primary and secondary outcome measures Blood samples from respondents were tested for total antibodies for SARS-CoV-2 using Wantai ELISA kits, and later positive samples were validated by Kantaro kits. Results More than half (55.3%) of the respondents were females, aged 23 median (IQR 14–35) years and more than half (58.4%) had no formal education. Overall, 2090 of 3446 study participants tested positive for SARS-CoV-2 antibody. The weighted and test adjusted seroprevalence (95% CI) was 48.3% (45.3% to 51.4%), which did not differ by the sexes. Children (aged 1–17 years) had a significantly lower seroprevalence 38.6% (95% CI 33.8% to 43.4%) compared with adults (58.1%, 95% CI 55.2% to 61.1%). Almost half (45.7%, 95% CI 41.9% to 49.5%) of seropositive individuals reported no relevant symptoms since March 2020. Antibody seroprevalence was higher in those with any comorbidity (57.8%, 95% CI 50.4% to 64.5%) than those without (47.2%, 95% CI 43.9% to 50.4%). Multivariate logistic regression analysis of all subjects identified increasing age and education as risk factors for seropositivity. In children (≤17 years), only age was significantly associated with the infection. Conclusions In December 2020, about half of the FDMNs had antibodies against SARS-CoV-2, including those who reported no history of symptoms. Periodic serosurveys are necessary to recommend appropriate public health measures to limit transmission.
- Open Access
Low back pain in the Bangladeshi adult population: a cross-sectional national survey
Objective Low back pain (LBP) is a common musculoskeletal disorder. This study aims to determine the residence-specific and sex-specific prevalence and the factors associated with LBP in Bangladesh. Methods The study subjects (aged ≥18 years) were identified from 20 primary sampling units of the national census following a cross-sectional multistage stratified sampling design. We considered the mechanical type of LBP for this study. A Bangla version of the modified Community Oriented Programme for Control of Rheumatic Disorders questionnaire was used. A team of trained field workers, rheumatology residents and rheumatologists collected the data. Analysis was done using weighted data. Results Two thousand subjects were approached, but 1843 could be screened. Among them, 561 had musculoskeletal disorders, and 343 were diagnosed with LBP. The weighted prevalence of LBP was 18.5% (95% CI: 11.8% to 25.2%) and age-standardised prevalence of LBP was 19.4% (95% CI: 14.0% to 24.8%), which was higher in women (27.2%, 19.3% to 35.1%) than men (14.0%, 8.7% to 19.3%). The prevalence persistently increased from age group 18–34 years (10.5%, 5.7 to 15.4) to ≥55 years (27.8%, 16.1% to 39.5%). People with no education had the highest prevalence (31.3%, 22.3% to 40.4%). The prevalence did not differ between urban and rural residential locations. Four factors were significantly associated with LBP: age (adjusted odds ratio: 2.4, 95% CI: 1.7 to 3.4), female sex (2.2, 1.5 to 3.3), absence of formal education (2.3, 1.6 to 3.3) and hypertension (1.7, 1.1 to 2.6). Conclusion LBP is a common problem in Bangladeshi adults. The factors identified are age, female sex, no formal education and hypertension. These should be addressed adequately to prevent and treat LBP.
Open AccessLow back pain in the Bangladeshi adult population: a cross-sectional national survey
Objective Low back pain (LBP) is a common musculoskeletal disorder. This study aims to determine the residence-specific and sex-specific prevalence and the factors associated with LBP in Bangladesh. Methods The study subjects (aged ≥18 years) were identified from 20 primary sampling units of the national census following a cross-sectional multistage stratified sampling design. We considered the mechanical type of LBP for this study. A Bangla version of the modified Community Oriented Programme for Control of Rheumatic Disorders questionnaire was used. A team of trained field workers, rheumatology residents and rheumatologists collected the data. Analysis was done using weighted data. Results Two thousand subjects were approached, but 1843 could be screened. Among them, 561 had musculoskeletal disorders, and 343 were diagnosed with LBP. The weighted prevalence of LBP was 18.5% (95% CI: 11.8% to 25.2%) and age-standardised prevalence of LBP was 19.4% (95% CI: 14.0% to 24.8%), which was higher in women (27.2%, 19.3% to 35.1%) than men (14.0%, 8.7% to 19.3%). The prevalence persistently increased from age group 18–34 years (10.5%, 5.7 to 15.4) to ≥55 years (27.8%, 16.1% to 39.5%). People with no education had the highest prevalence (31.3%, 22.3% to 40.4%). The prevalence did not differ between urban and rural residential locations. Four factors were significantly associated with LBP: age (adjusted odds ratio: 2.4, 95% CI: 1.7 to 3.4), female sex (2.2, 1.5 to 3.3), absence of formal education (2.3, 1.6 to 3.3) and hypertension (1.7, 1.1 to 2.6). Conclusion LBP is a common problem in Bangladeshi adults. The factors identified are age, female sex, no formal education and hypertension. These should be addressed adequately to prevent and treat LBP.
- Open Access
Prevalence of blindness and its determinants in Bangladeshi adult population: results from a national cross-sectional survey
Objective The objective of this study was to determine the prevalence of blindness and its determinants in Bangladeshi adult population. Study design A cross-sectional population-based survey conducted at household level with national representation. Samples were drawn from the 2011 national census frame using a multistage stratified cluster sampling method. Setting and participants The survey was done in urban and rural areas in 2013 using a probability proportionate to size sampling approach to locate participants from 72 primary sampling units. One man or one woman aged ≥40 years was randomly selected from their households to recruit 7200. In addition to sociodemographic data, information on medication for hypertension and diabetes was obtained. Blood pressure and capillary blood glucose were measured. Eyelids, cornea, lens, and retina were examined in addition to visual acuity and refraction testing. Primary outcome measures The following definition was used to categorise subjects having (1) blindness: visual acuity Results We could recruit 6391 (88.8%) people among whom 2955 (46.2%) were men. Among them, 1922 (30.1%) were from urban and 4469 (69.9%) were from rural areas. The mean age was 54.3 (SD 11.2) years. The age-standardised prevalence, after best correction, of blindness and low vision was 1.0% (95% CI 0.5% to 1.4%) and 12.1% (95% CI 10.5% to 13.8%), respectively. Multivariable logistic regression indicated that cataract, age-related macular degeneration and diabetic retinopathy were significantly associated with low vision and blindness after adjustment for age and sex. Population attributable risk of cataract for low vision and blindness was 79.6%. Conclusions Low vision and blindness are common problems in those aged 40 years or older. Extensive screening and eye care services are necessary for wider coverage engaging all tiers of the healthcare system especially focusing on cataract.
Open AccessPrevalence of blindness and its determinants in Bangladeshi adult population: results from a national cross-sectional survey
Objective The objective of this study was to determine the prevalence of blindness and its determinants in Bangladeshi adult population. Study design A cross-sectional population-based survey conducted at household level with national representation. Samples were drawn from the 2011 national census frame using a multistage stratified cluster sampling method. Setting and participants The survey was done in urban and rural areas in 2013 using a probability proportionate to size sampling approach to locate participants from 72 primary sampling units. One man or one woman aged ≥40 years was randomly selected from their households to recruit 7200. In addition to sociodemographic data, information on medication for hypertension and diabetes was obtained. Blood pressure and capillary blood glucose were measured. Eyelids, cornea, lens, and retina were examined in addition to visual acuity and refraction testing. Primary outcome measures The following definition was used to categorise subjects having (1) blindness: visual acuity Results We could recruit 6391 (88.8%) people among whom 2955 (46.2%) were men. Among them, 1922 (30.1%) were from urban and 4469 (69.9%) were from rural areas. The mean age was 54.3 (SD 11.2) years. The age-standardised prevalence, after best correction, of blindness and low vision was 1.0% (95% CI 0.5% to 1.4%) and 12.1% (95% CI 10.5% to 13.8%), respectively. Multivariable logistic regression indicated that cataract, age-related macular degeneration and diabetic retinopathy were significantly associated with low vision and blindness after adjustment for age and sex. Population attributable risk of cataract for low vision and blindness was 79.6%. Conclusions Low vision and blindness are common problems in those aged 40 years or older. Extensive screening and eye care services are necessary for wider coverage engaging all tiers of the healthcare system especially focusing on cataract.
- Open Access
- 5 March 2022
- Published by Wiley in Lifestyle Medicine
- Vol. 3 (2)
Facing the challenges of smokeless tobacco epidemic in Bangladesh
Background: Smokeless tobacco (SLT) use in Bangladesh is one of the highest in the world. Despite having a tobacco control programme, the use of SLTs has increased in recent years. The objective of this paper is to report on the prevalence of SLTs and challenges faced during control measures in Bangladesh.Methods: A wide range of published reports on tobacco in general and SLT were reviewed. Websites of relevant organizations and national survey reports including PubMed were visited to identify national‐ or subnational‐level data. Legislations, policies and their implementation and programmes are reviewed. Additional data were captured by active surveys on SLT products, especially on graphic health warning. The authors’ perspectives on SLT control in Bangladesh were captured through a series of brainstorming sessions.Findings: The reported prevalence of SLTs ranged from 21% to 26% among adults. SLT control measures are not adequately addressed despite the existence of several policies and programmes. It is based to the definition of Tobacco Control ACT in 2013. We propose inadequate prioritization and weak policy directives; unregulated industry leading to high production, marketing, violation of package warning and tax evasion; high level of cultural acceptance; and poor awareness of the people as challenges to the control efforts. In addition, a lenient attitude of the government towards the so‐called “cottage” industry made SLTs unabated. We propose prioritization of SLT control, strengthening industry monitoring and tax measures, countering cultural acceptability and public ignorance and cessation support engaging government and civil society organizations as the way forward.Conclusion: The control measures should be evidence‐based warranting operational research. Government and non‐government organizations’ collaborative efforts on an immediate, short‐and long‐term basis are recommended to meet the challenges of SLTs. These primarily include policy support for prioritization, enforcement of legislation, industry and marketing regulation, stringent tax measures, denormalizing societal acceptability and cessation support.
- 5 March 2022
- Published by Wiley in Lifestyle Medicine
- Vol. 3 (2)
Open AccessFacing the challenges of smokeless tobacco epidemic in Bangladesh
Background: Smokeless tobacco (SLT) use in Bangladesh is one of the highest in the world. Despite having a tobacco control programme, the use of SLTs has increased in recent years. The objective of this paper is to report on the prevalence of SLTs and challenges faced during control measures in Bangladesh.Methods: A wide range of published reports on tobacco in general and SLT were reviewed. Websites of relevant organizations and national survey reports including PubMed were visited to identify national‐ or subnational‐level data. Legislations, policies and their implementation and programmes are reviewed. Additional data were captured by active surveys on SLT products, especially on graphic health warning. The authors’ perspectives on SLT control in Bangladesh were captured through a series of brainstorming sessions.Findings: The reported prevalence of SLTs ranged from 21% to 26% among adults. SLT control measures are not adequately addressed despite the existence of several policies and programmes. It is based to the definition of Tobacco Control ACT in 2013. We propose inadequate prioritization and weak policy directives; unregulated industry leading to high production, marketing, violation of package warning and tax evasion; high level of cultural acceptance; and poor awareness of the people as challenges to the control efforts. In addition, a lenient attitude of the government towards the so‐called “cottage” industry made SLTs unabated. We propose prioritization of SLT control, strengthening industry monitoring and tax measures, countering cultural acceptability and public ignorance and cessation support engaging government and civil society organizations as the way forward.Conclusion: The control measures should be evidence‐based warranting operational research. Government and non‐government organizations’ collaborative efforts on an immediate, short‐and long‐term basis are recommended to meet the challenges of SLTs. These primarily include policy support for prioritization, enforcement of legislation, industry and marketing regulation, stringent tax measures, denormalizing societal acceptability and cessation support.
- Open Access
- 12 August 2020
- Published by Wiley in Epilepsia Open
- Vol. 5 (4) , 526-536
Prevalence of epilepsy in Bangladesh: Results from a national household survey
Objective: To determine the prevalence and types of epilepsy in Bangladesh.Methods: We conducted a nationwide population‐based cross‐sectional survey among Bangladeshi population of all ages, except children under one month. We surveyed 9839 participants (urban, 4918; rural, 4920) recruited at their households using multistage cluster sampling. Trained physicians with neurology background confirmed the diagnosis of suspected epilepsy cases identified by interviewer‐administered questionnaires. We reported the overall and sex, residence, and age groups‐specific prevalence of epilepsy per 1000 populations with 95% confidence interval.Results: The national prevalence of epilepsy per 1000 was 8.4 (95% CI 5.6‐11.1), urban 8.0 (4.6‐11.4), and rural 8.5 (5.60‐11.5). The prevalence in adult males and females was 9.2 (5.7‐12.6) and 7.7 (3.6‐11.7), respectively. The prevalence in children aged <18 years (8.2, 3.4‐13.0 was similar to adults (8.5 (5.4‐11.4). Among all epilepsy cases, 65.1% had active epilepsy. Their (active epilepsy) prevalence was 5.8 (3.5‐8.1). Of them, 63.4% were not receiving treatment. Moreover, those who received allopathy treatment, 72.5% had low adherence leading to a high treatment gap.Significance: Our findings out of this first‐ever national survey were similar to other Asian countries. However, the prevalence of active epilepsy and treatment gap were considerably higher. This study serves useful evidence for tailoring interventions aimed to reduce the burden of epilepsy—primarily through targeted community awareness program—and access to antiepileptic treatment in health facilities in Bangladesh.
- 12 August 2020
- Published by Wiley in Epilepsia Open
- Vol. 5 (4) , 526-536
Open AccessPrevalence of epilepsy in Bangladesh: Results from a national household survey
Objective: To determine the prevalence and types of epilepsy in Bangladesh.Methods: We conducted a nationwide population‐based cross‐sectional survey among Bangladeshi population of all ages, except children under one month. We surveyed 9839 participants (urban, 4918; rural, 4920) recruited at their households using multistage cluster sampling. Trained physicians with neurology background confirmed the diagnosis of suspected epilepsy cases identified by interviewer‐administered questionnaires. We reported the overall and sex, residence, and age groups‐specific prevalence of epilepsy per 1000 populations with 95% confidence interval.Results: The national prevalence of epilepsy per 1000 was 8.4 (95% CI 5.6‐11.1), urban 8.0 (4.6‐11.4), and rural 8.5 (5.60‐11.5). The prevalence in adult males and females was 9.2 (5.7‐12.6) and 7.7 (3.6‐11.7), respectively. The prevalence in children aged <18 years (8.2, 3.4‐13.0 was similar to adults (8.5 (5.4‐11.4). Among all epilepsy cases, 65.1% had active epilepsy. Their (active epilepsy) prevalence was 5.8 (3.5‐8.1). Of them, 63.4% were not receiving treatment. Moreover, those who received allopathy treatment, 72.5% had low adherence leading to a high treatment gap.Significance: Our findings out of this first‐ever national survey were similar to other Asian countries. However, the prevalence of active epilepsy and treatment gap were considerably higher. This study serves useful evidence for tailoring interventions aimed to reduce the burden of epilepsy—primarily through targeted community awareness program—and access to antiepileptic treatment in health facilities in Bangladesh.
- Open Access
- 7 August 2020
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 15 (1) , 54
Correction: Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
This article details a correction to the article: Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, et al. Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Global Heart. 2020; 15(1): 44. DOI: http://doi.org/10.5334/gh.823
- 7 August 2020
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 15 (1) , 54
Open AccessCorrection: Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
This article details a correction to the article: Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, et al. Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings. Global Heart. 2020; 15(1): 44. DOI: http://doi.org/10.5334/gh.823
- Open Access
- 6 August 2020
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 15 (1) , 52
Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality
Non-vitamin K antagonist oral anticoagulants (NOACs) represent a paradigm shift in the treatment of non-valvular atrial fibrillation (AF) with major practice guidelines around the world recommending NOACs over vitamin K antagonist oral anticoagulants for initial treatment of AF for stroke prevention. Here we describe the evidence collated and the process followed for the successful inclusion of NOACs into the 21st WHO Model List of Essential Medicines (EML).
- 6 August 2020
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 15 (1) , 52
Open AccessInclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality
Non-vitamin K antagonist oral anticoagulants (NOACs) represent a paradigm shift in the treatment of non-valvular atrial fibrillation (AF) with major practice guidelines around the world recommending NOACs over vitamin K antagonist oral anticoagulants for initial treatment of AF for stroke prevention. Here we describe the evidence collated and the process followed for the successful inclusion of NOACs into the 21st WHO Model List of Essential Medicines (EML).
- Open Access
- 1 July 2020
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 15 (1) , 44
Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
In this paper, we provide recommendations on the management of cardiovascular disease (CVD) among patients with confirmed or suspected coronavirus disease (COVID-19) to facilitate the decision making of healthcare professionals in low resource settings. The emergence of novel coronavirus disease, also known as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions, leading to a pandemic. There is concern that COVID-19 is cardiotropic, and it interacts with the cardiovascular system on multiple levels. Individuals with established CVD are more susceptible to severe COVID-19. Through a consensus approach involving an international group this WHF statement summarizes the links between cardiovascular disease and COVID-19 and present some practical recommendations for the management of hypertension and diabetes, acute coronary syndrome, heart failure, rheumatic heart disease, Chagas disease, and myocardial injury for patients with COVID-19 in low-resource settings. This document is not a clinical guideline and it is not intended to replace national clinical guidelines or recommendations. Given the rapidly growing burden posed by COVID-19 illness and the associated severe prognostic implication of CVD involvement, further research is required to understand the potential mechanisms linking COVID-19 and CVD, clinical presentation, and outcomes of various cardiovascular manifestations in COVID-19 patients. Publisher's Note: A corrigendum relating to this article has been published and can be found at http://doi.org/10.5334/gh.885
- 1 July 2020
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 15 (1) , 44
Open AccessManagement of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
In this paper, we provide recommendations on the management of cardiovascular disease (CVD) among patients with confirmed or suspected coronavirus disease (COVID-19) to facilitate the decision making of healthcare professionals in low resource settings. The emergence of novel coronavirus disease, also known as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented global challenge for the healthcare community. The ability of SARS-CoV-2 to get transmitted during the asymptomatic phase and its high infectivity have led to the rapid transmission of COVID-19 beyond geographic regions, leading to a pandemic. There is concern that COVID-19 is cardiotropic, and it interacts with the cardiovascular system on multiple levels. Individuals with established CVD are more susceptible to severe COVID-19. Through a consensus approach involving an international group this WHF statement summarizes the links between cardiovascular disease and COVID-19 and present some practical recommendations for the management of hypertension and diabetes, acute coronary syndrome, heart failure, rheumatic heart disease, Chagas disease, and myocardial injury for patients with COVID-19 in low-resource settings. This document is not a clinical guideline and it is not intended to replace national clinical guidelines or recommendations. Given the rapidly growing burden posed by COVID-19 illness and the associated severe prognostic implication of CVD involvement, further research is required to understand the potential mechanisms linking COVID-19 and CVD, clinical presentation, and outcomes of various cardiovascular manifestations in COVID-19 patients. Publisher's Note: A corrigendum relating to this article has been published and can be found at http://doi.org/10.5334/gh.885
- 1 January 2020
- Published by SAGE Publications
Weighting National Survey Data for Bangladeshi Population
- 1 January 2020
- Published by SAGE Publications
Weighting National Survey Data for Bangladeshi Population